TECHNETIUM TC 99M SULFUR COLLOID by GE HealthCare is 99m decays by isomeric transition, emitting a photon that can be detected for imaging purposes. First approved in 1974.
Drug data last refreshed 14h ago · AI intelligence enriched 6d ago
Technetium Tc 99m Sulfur Colloid is a radioactive diagnostic imaging agent approved in 1974 that uses gamma photon emission for scintigraphic visualization of lymphatic, reticuloendothelial, and gastrointestinal systems. It functions through uptake by the reticuloendothelial system (RES) following intravenous injection, or by lymphatic transport and clearance assessment when administered subcutaneously or intraperitoneally. Oral administration enables esophageal transit studies, reflux scintigraphy, and aspiration detection.
Product approaching loss of exclusivity with minimal current linked job opportunities; team likely focused on lifecycle management and margin protection rather than growth initiatives.
99m decays by isomeric transition, emitting a photon that can be detected for imaging purposes. Following subcutaneous injection, Technetium Tc 99m Sulfur Colloid enters the lymphatic capillaries and is transported with lymph to lymph nodes. However, when there is massive nodal metastatic…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Technetium Tc 99m Sulfur Colloid Injection for Tracing Sentinel Nodes in Breast Cancer
Worked on TECHNETIUM TC 99M SULFUR COLLOID at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on Technetium Tc 99m Sulfur Colloid offers deep expertise in nuclear diagnostics, regulatory compliance, and lifecycle management in a mature product environment. Career progression favors operational excellence, regulatory navigation, and cross-functional project leadership rather than commercial growth or innovation.